Skba Capital Management LLC Astrazeneca PLC Transaction History

Skba Capital Management LLC

$599 Million
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$69.91 - $75.81 $27,964 - $30,324	-400 Reduced 0.54%	73,535 $5.26 Million
Q1 2023 May 11, 2023	SELL	$63.15 - $71.6 $65,360 - $74,106	-1,035 Reduced 1.38%	73,935 $5.13 Million
Q4 2022 Feb 10, 2023	SELL	$54.21 - $70.44 $23,635 - $30,711	-436 Reduced 0.58%	74,970 $5.08 Million
Q3 2022 Nov 10, 2022	SELL	$53.02 - $135.75 $8,695 - $22,263	-164 Reduced 0.22%	75,406 $4.14 Million
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $2.66 Million - $3.19 Million	-44,900 Reduced 37.27%	75,570 $4.99 Million
Q1 2022 May 12, 2022	SELL	$55.72 - $67.12 $61,292 - $73,832	-1,100 Reduced 0.9%	120,470 $7.99 Million
Q4 2021 Feb 10, 2022	SELL	$54.02 - $63.83 $27,010 - $31,915	-500 Reduced 0.41%	121,570 $7.08 Million
Q2 2021 Aug 12, 2021	SELL	$48.42 - $60.18 $2.82 Million - $3.5 Million	-58,200 Reduced 32.28%	122,070 $7.31 Million
Q1 2021 May 13, 2021	BUY	$47.16 - $54.44 $3.89 Million - $4.49 Million	82,400 Added 84.19%	180,270 $8.96 Million
Q4 2020 Feb 10, 2021	SELL	$48.52 - $58.02 $2.17 Million - $2.59 Million	-44,700 Reduced 31.35%	97,870 $4.89 Million
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $498,858 - $574,340	-9,400 Reduced 6.19%	142,570 $7.81 Million
Q2 2020 Aug 12, 2020	SELL	$43.1 - $55.31 $68,960 - $88,496	-1,600 Reduced 1.04%	151,970 $8.04 Million
Q1 2020 May 14, 2020	SELL	$37.79 - $51.33 $2.34 Million - $3.17 Million	-61,800 Reduced 28.69%	153,570 $6.86 Million
Q4 2019 Feb 12, 2020	SELL	$42.46 - $50.46 $692,098 - $822,498	-16,300 Reduced 7.04%	215,370 $10.7 Million
Q3 2019 Nov 12, 2019	SELL	$40.12 - $45.47 $28,084 - $31,829	-700 Reduced 0.3%	231,670 $10.3 Million
Q2 2019 Aug 12, 2019	SELL	$37.28 - $41.68 $365,344 - $408,464	-9,800 Reduced 4.05%	232,370 $9.59 Million
Q1 2019 May 13, 2019	SELL	$35.49 - $43.02 $855,309 - $1.04 Million	-24,100 Reduced 9.05%	242,170 $9.79 Million
Q4 2018 Feb 07, 2019	SELL	$36.86 - $41.49 $715,084 - $804,906	-19,400 Reduced 6.79%	266,270 $10.1 Million
Q3 2018 Nov 09, 2018	BUY	$34.76 - $39.72 $2.26 Million - $2.58 Million	65,000 Added 29.46%	285,670 $11.3 Million
Q2 2018 Aug 10, 2018	SELL	$34.55 - $37.05 $134,745 - $144,495	-3,900 Reduced 1.74%	220,670 $7.75 Million
Q1 2018 May 08, 2018	SELL	$32.97 - $36.63 $16,485 - $18,315	-500 Reduced 0.22%	224,570 $7.85 Million
Q4 2017 Feb 09, 2018	SELL	$32.09 - $34.78 $3,209 - $3,478	-100 Reduced 0.04%	225,070 $7.81 Million
Q3 2017 Nov 08, 2017	BUY	$28.96 - $34.0 $6.52 Million - $7.66 Million	225,170	225,170 $7.63 Million

Others Institutions Holding AZN

# of Institutions

1,343

Shares Held

492M

Call Options Held

4.99M

Put Options Held

3.19M

Price T Rowe Associates Inc Baltimore, MD

64.9M
Shares

$4.88 Billion
0.61% of portfolio
Primecap Management CO Pasadena, CA

42.6M
Shares

$3.2 Billion
2.44% of portfolio
Wellington Management Group LLP Boston, MA

40.6M
Shares

$3.05 Billion
0.58% of portfolio
Capital International Investors Los Angeles, CA

36.7M
Shares

$2.76 Billion
0.6% of portfolio
Franklin Resources Inc San Mateo, CA

17.6M
Shares

$1.32 Billion
0.44% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skba Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Skba Capital Management LLC with notifications on news.

Account